DRZID
IMMU

DePrince Race & Zollo Inc (DRZ)’s Immunomedics Inc IMMU Stock Holding History

DePrince Race & Zollo Inc (DRZ)’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-24,828
Closed -$517K – 242
2018
Q3 		$517K Buy
+24,828
New +$588K 0.01% 216

Other funds holding IMMU

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

DePrince Race & Zollo Inc (DRZ)'s IMMU Position: Q4 2018 in Review

DePrince Race & Zollo Inc (DRZ) sold out of Immunomedics Inc (IMMU) in Q4 2018, closing a stake of 24,828 shares — an estimated $517K sold.

DePrince Race & Zollo Inc (DRZ) first reported a position in IMMU in Q3 2018 and held it in 1 quarter. The position peaked at $517K in Q3 2018. 205 funds tracked by Wall St. Rank hold IMMU as of Q4 2018.

  • DePrince Race & Zollo Inc (DRZ) reported no remaining Immunomedics Inc position as of Q4 2018 after selling out during the quarter.
  • DePrince Race & Zollo Inc (DRZ) sold 24,828 Immunomedics Inc shares in Q4 2018, an estimated $517K.
  • DePrince Race & Zollo Inc (DRZ) first reported a position in Immunomedics Inc in Q3 2018 and held it in 1 quarter.
  • DePrince Race & Zollo Inc (DRZ)'s Immunomedics Inc position peaked at $517K in Q3 2018.
  • 205 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2018.

Based on DePrince Race & Zollo Inc (DRZ)'s 13F filing for Q4 2018, filed 30 Jan 2019.